Praxis Precision Medicines (PRAX) director Form 3 shows no stock owned

Rhea-AI Filing Summary

Praxis Precision Medicines, Inc. filed an initial ownership report for director Jeffrey B. Kindler as of 01/08/2026. The filing is a Form 3, which is used when someone first becomes an insider such as a director or officer.

In the remarks, the report states that no securities are beneficially owned, meaning the reporting person did not report holding any Praxis Precision Medicines stock or derivative securities at the time of this filing. The form is signed by an attorney-in-fact under a power of attorney dated 01/12/2026.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

KINDLER JEFFREY B

(Last) (First) (Middle)

C/O PRAXIS PRECISION MEDICINES, INC.

99 HIGH STREET, 30TH FLOOR

(Street)

BOSTON MA 02110

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/08/2026

3. Issuer Name and Ticker or Trading Symbol
Praxis Precision Medicines, Inc. [ PRAX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Alex Nemiroff, as Attorney-in-Fact	01/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the Praxis Precision Medicines (PRAX) Form 3 report show?

The Form 3 reports that director Jeffrey B. Kindler had no securities beneficially owned in Praxis Precision Medicines, Inc. as of 01/08/2026.

Who is the reporting person in the PRAX Form 3 filing?

The reporting person is Jeffrey B. Kindler, who is identified in the filing as a director of Praxis Precision Medicines, Inc.

Does Jeffrey B. Kindler hold any Praxis Precision Medicines shares according to this Form 3?

According to the remarks section, the filing states that no securities are beneficially owned by the reporting person at the time of the Form 3.

What is the event date for the Praxis Precision Medicines Form 3?

The Form 3 lists the Date of Event Requiring Statement as 01/08/2026.

Who signed the Praxis Precision Medicines Form 3 for Jeffrey B. Kindler?

The Form 3 is signed "/s/ Alex Nemiroff, as Attorney-in-Fact" on 01/12/2026, reflecting a power of attorney arrangement.

Does this PRAX Form 3 include any transactions in company stock or options?

No. The Form 3 does not list any transactions in non-derivative or derivative securities and explicitly notes that no securities are beneficially owned.